86
Views
13
CrossRef citations to date
0
Altmetric
Research Article

METABOLIC ACTIVATION CAPACITY OF NEONATAL MICE IN RELATION TO THE NEONATAL MOUSE TUMORIGENICITY BIOASSAY

, , , , , & show all
Pages 241-266 | Published online: 04 Jun 2000

REFERENCES

  • Guidelines for Carcinogen Bioassay in Small Rodents. NCI-CG-TR-1, DHEW/PHS/NIH/NCI, Washington, DC 1976
  • Weisburger E. K. History of the bioassay program of the National Cancer Institute. Prog. Exp. Tumor Res. 1983; 26: 187–201
  • The National Toxicology Program. Identifying and Regulating Carcinogens. OTA-BP-H-42, U.S. Government Printing Office, Washington, DC 1987; 145-167
  • Ames B. N., Gold L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990; 249: 970–971
  • Contrera J. F., Jacobs A. C., DeGeorge J. J. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul. Toxicol. Pharmacol. 1997; 25: 130–145
  • Flammang T. J., Von Tungeln L. S., Kadlubar F. F., Fu P. P. Neonatal mouse assay for tumorigenicity: Alternative to the chronic rodent bioassay. Regul. Toxicol. Pharmacol. 1997; 26: 230–240
  • Fu P. P., Von Tungeln L. S., Yi P., Xia Q., Casciano D. A., Flammang T. J., Kadlubar F. F. Neonatal mouse tumorigenicity bioassay. Drug Inform. J. 1998; 32: 711–728
  • DHHS/FDA/ICH International Conference on Harmonization: Draft Guidelines on Testing for Carcinogenicity of Pharmaceuticals. Fed. Reg. 1996; 61: 43,298-43,300
  • Pietra G., Spencer K., Shubik P. Response of newly born mice to a chemical carcinogen. Nature 1959; 183: 1689
  • Pietra G., Rappaport H., Shubik P. The effects of carcinogenic chemicals in newborn mice. Cancer 1961; 14: 308–317
  • Della Porta G., Terracini B. Chemical carcinogenesis in infant animals. Prog. Exp. Tumor Res. 1969; 11: 334–363
  • Della Porta G., Capitano J., Parmi L., Colnaghi M. I. Urethan carcinogenesis in newborn, suckling, and adult mice of C57BL, C3H, BC3F1, C3Hf, and SWR strains. Tumori 1967; 53: 81–102
  • Flaks A. The effect if 9, 10-dimethyl-1,2-benzanthracene on young mice of low and high cancer strain. Br. J. Cancer 1965; 19: 547–550
  • Toth B., Rappaport H., Shubik P. Accelerated development of malignant lymphomas in AKR mice injected at birth with 7,12-dimethylbenz(a)anthracene. Proc. Soc. Exp. Biol. Med. 1962; 110: 881–884
  • Toth B., Rappaport H., Shubik P. The influence of dose and age on the induction of malignant lymphomas and other tumors by 7,12-dimethylbenz(a)anthracene in Swiss mice. J. Natl. Cancer Inst. 1963; 30: 723–741
  • Toth B. A critical review of experiments in chemical carcinogenesis using newborn animals. Cancer Res. 1968; 28: 727–738
  • Vesselinovitch S. D., Mihailovich N. Significance of newborn age and dose of urethan in leukomogenesis. Cancer Res. 1966; 26: 1633–1637
  • Walters M. A. The induction of lung tumors by the injection of 9,10-dimethyl-1,2-benzanthracene (DMBA) into newborn suckling and young adult mice. Br. J. Cancer 1966; 20: 148–160
  • Walters M. A., Roe F. J. The time of appearance of lung tumours in mice injected when newly born with 9,10-dimethyl-1,2-benzanthracene (DMBA). Br. J. Cancer 1966; 20: 161–167
  • Chieco-Bianchi L., Fiore-Donati L., Tridente G., De Benedictis G. Role of age and other factors influencing the oncogenic effect of chemical carcinogens in mice. Tumori 1965; 51: 53–68
  • Klein M. Induction of lymphocytic neoplasms, hepatomas, and other tumors after oral administration of urethan to infant mice. J. Natl. Cancer Inst. 1962; 29: 1035–1046
  • Kelly M. G., Newton W. L., O'Gara R. W. Susceptibility of newborn germ-free mice to tumor induction by 3-methylcholanthrene. Cancer Res 1963; 23: 978–983
  • Roe F. J. C., Mitchley B. C. V., Walters M. Tests for carcinogenesis using newborn mice: 1,2-Benzanthracene, 2-naphthylamine, 2-naphthylhydroxylamine and ethyl methane sulphonate. Br. J. Cancer 1963; 17: 255–260
  • Roe F. J. C., Millican D., Mallety J. M. Induction of melanotic lesions of the iris in rats by urethane given during the neonatal period. Nature 1963; 199: 1201–1202
  • Roe F. J., Waters M. A. Induction of hepatoma in mice by carcinogens of the polycyclic hydrocarbon type. Nature 1967; 214: 299–300
  • Vesselinovitch S. D., Rao K. V., Mihailovich N. Neoplastic response of mouse tissues during perinatal age periods and its significance in chemical carcinogenesis. Natl. Cancer Inst. Monogr. 1979; 51: 239–250
  • Vesselinovitch S. D. Perinatal mouse liver carcinogenesis as a sensitive carcinogenesis model and the role of the sex hormonal environment in tumor development. Prog. Clin. Biol. Res. 1990; 331: 53–68
  • Vesselinovitch S. D., Mihailovich N., Itze L. Comparative studies on the kinetics of the neoplasic competence in mice. Cancer Res. 1970; 30: 2548–2551
  • Vesselinovitch S. D., Mihailovich N., Rao K. V., Itze L. Perinatal carcinogenesis by urethan. Cancer Res. 1971; 31: 2143–2147
  • Dooley K. L., Stavenuiter J. F., Westra J. G., Kadlubar F. F. Comparative carcinogenicity of the food pyrolysis product, 2-amino-5-phenylpyridine, and the known human carcinogen, 4-aminobiphenyl, in the neonatal B6C3F1 mouse. Cancer Lett. 1988; 41: 99–103
  • Dooley K. L., Von Tungeln L. S., Bucci T., Fu P. P., Kadlubar F. F. Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse. Cancer Lett. 1992; 62: 205–209
  • Hecht S. S., Radok L., Amin S., Huie K., Melikian A. A., Hoffmann D., Pataki J., Harvey R. G. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin. Cancer Res. 1985; 45: 1449–1452
  • Fu P. P., Von Tungeln L. S., Zhan D. J., Bucci T. Potent tumorigenicity of 7-chlorobenz[a]anthracene and 7-bromobenz[a]anthracene in the neonatal B6C3F1 male mouse. Cancer Lett. 1996; 101: 37–42
  • Wiseman R. W., Miller E. C., Miller J. A., Liem A. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J × C3H/HeJ F1 mice. Cancer Res. 1987; 47: 2275–2283
  • Lai C. C., Miller E. C., Miller J. A., Liem A. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts. Carcinogenesis 1987; 8: 471–478
  • LaVoie E. J., He Z. M., Wu Y., Meschter C. L., Weyand E. H. Tumorigenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-diol epoxides in newborn mice. Cancer Res. 1994; 54: 962–968
  • Conney A. H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 1982; 42: 4875–4917
  • Fujii K. Evaluation of the newborn mouse model for chemical tumorigenesis. Carcinogenesis 1991; 12: 1409–1415
  • Xia Q., Yi P., Zhan D. -J., Von Tungeln L. S., Hart R. W., Heflich R. H., Fu P. P. Liver tumors induced in B6C3F1 mice by 7-chlorobenz[a]anthracene and 7-bromobenz[a]anthracene contain K-ras oncogene mutations. Cancer Lett. 1998; 123: 21–25
  • Wislocki P. G., Bagan E. S., Lu A. Y., Dooley K. L., Fu P. P., Han-Hsu H., Beland F. A., Kadlubar F. F. Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay. Carcinogenesis 1986; 7: 1317–1322
  • Fu P. P., Von Tungeln L. S., Unruh L. E., Ni Y. C., Chou M. W. Comparative regioselective and stereoselective metabolism of 7-chlorobenz[a]anthracene and 7-bromobenz[a]anthracene by mouse and rat liver microsomes. Carcinogenesis 1991; 12: 371–378
  • Von Tungeln L. S., Xia Q., Bucci T., Heflich R. H., Fu P. P. Tumorigenicity and liver tumorras-protooncogene mutations in CD-1 mice treated neonatally with 1- and 3-nitrobenzo[a]pyrene and their trans-7,8-dihydrodiol aminobenzo[a]py-rene metabolites. Cancer Lett. 1999; 137: 137–143
  • Epstein S. S., Joshi S., Andrea J., Mantel N., Sawicki E., Stanley T., Tabor E. C. Carcinogenicity of organic particulate pollutants in urban air after administration of trace quantities to neonatal mice. Nature 1966; 212: 1305–1307
  • Lewtas J., Dooley K., Von Tungeln L., Fu P., Savela K., Gallagher J., Kadlubar F. Comparative tumorigenicity of complex environmental mixtures in the newborn mouse and mouse skin tumor assays. Proc. Am. Assoc. Cancer Res. 1993; 34: A697
  • Boberg E. W., Miller E. C., Miller J. A., Poland A., Liem A. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res. 1983; 43: 5163–5173
  • Delclos K. B., Tarpley W. G., Miller E. C., Miller J. A. 4-Aminoazobenzene and N,N-dimethyl-4-aminoazobenzene as equipotent hepatic carcinogens in male C57BL/6 × C3H/He F1 mice and characterization of N-(deoxyguanosin-8-yl)-4-aminoazobenzene as the major persistent hepatic DNA-bound dye in these mice. Cancer Res. 1984; 44: 2540–2550
  • Delclos K. B., Miller E. C., Miller J. A., Liem A. Sulfuric acid esters as major ultimate electrophilic and hepatocarcinogenic metabolites of 4-aminoazobenzene and its N-methyl derivatives in infant male C57BL/6J × C3H/HeJ F1 (B6C3F1) mice. Carcinogenesis 1986; 7: 277–287
  • Fennell T. R., Wiseman R. W., Miller J. A., Miller E. C. Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1′-hydroxy-2′,3′-dehydroestragole in infant male C57BL/6J × C3H/HeJ F1 mice. Cancer Res. 1985; 45: 5310–5320
  • Leithauser M. T., Liem A., Stewart B. C., Miller E. C., Miller J. A. 1, N6-Ethenoadenosine formation, mutagenicity and murine tumor induction as indicators of the generation of an electrophilic epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate. Carcinogenesis 1990; 11: 463–473
  • Lai C. C., Miller J. A., Miller E. C., Liem A. N-Sulfooxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57/6J × C3H/HeJ F1 (B6C3F1) mice. Carcinogenesis 1985; 6: 1037–1045
  • Von Tungeln L. S., Bucci T., Kadlubar F. F., Fu P. P. Tumorigenicity of nitro-polycyclic aromatic hydrocarbons in the neonatal B6C3F1 male mouse. Proc. Am. Assoc. Cancer Res. 1994; 35: A969
  • Fu P. P., Dooley K. L., Von Tungeln L. S., Bucci T., Hart R. W., Kadlubar F. F. Caloric restriction profoundly inhibits liver tumor formation after initiation by 6-nitrochrysene in male mice. Carcinogenesis 1994; 15: 159–161
  • Von Tungeln L. S., Bucci T. J., Hart R. W., Kadlubar F. F., Fu P. P. Inhibitory effect of caloric restriction on tumorigenicity induced by 4-aminobiphenyl and 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) in the CD1 newborn mouse bioassay. Cancer Lett. 1996; 104: 133–136
  • Herreno-Saenz D., Heflich R. H., Von Tungeln L. S., Lewtas J., Fu P. P. DNA adduct formation by 2-nitrofluoranthene in Salmonella typhimurium and neonatal B6C3F1 mice. Polycycl. Arom. Compounds 1994; 6: 79–85
  • Von Tungeln L. S., unpublished data
  • Melnick R. L., Kohn M. C., Portier C. J. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis. Environ. Health Perspect 1996; 104: 123–134
  • Kapitulnik J., Wislocki P. G., Levin W., Yagi H., Thakker D. R., Akagi H., Koreeda M., Jerina D. M., Conney A. H. Marked differences in the carcinogenic activity of optically pure (+)- and (−)-trans-7,8-dihydrobenzo(a)pyrene in newborn mice. Cancer Res. 1978; 38: 2661–2665
  • Wislocki P. G., Kapitulnik J., Levin W., Conney A. H. Tumorigenicity of benzo[a]pyrene 4,5-, 7,8-,10- and 11,12-oxides in newborn mice. Cancer Lett. 1978; 5: 191–197
  • Von Tungeln L. S., Yi P., Kadlubar F. F., Fu P. P. Tumorigenicity of chloral hydrate (CH), trichloroacetic acid (TCA), trichloroethanol (TCE), and malondialdehyde (MDA) in the B6C3F1 neonatal mouse. Proc. Am. Assoc. Cancer Res. 1997; 38: A2370
  • Von Tungeln L. S., Xia Q., Herreno-Saenz D., Bucci T. J., Heflich R. H., Fu P. P. Tumorigenicity of nitropolycyclic aromatic hydrocarbons in the neonatal B6C3F1 mouse bioassay and characterization of ras mutations in liver tumors from treated mice. Cancer Lett. 1999; 146: 1–7
  • Fox T. R., Schumann A. M., Watanabe P. G., Yano B. L., Maher V. M., McCormick J. J. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6× C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res. 1990; 50: 4014–4019
  • Reynolds S. H., Stowers S. J., Patterson R. M., Maronpot R. R., Aaronson S. A., Anderson M. W. Activated oncogenes in B6C3F1 mouse liver tumors: Implications for risk assessment. Science 1987; 237: 1309–1316
  • Wiseman R. W., Stowers S. J., Miller E. C., Anderson M. W., Miller J. A. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc. Natl. Acad. Sci. USA 1986; 83: 5825–5829
  • Goodman J. I., Ward J. M., Popp J. A., Klaunig J. E., Fox T. R. Mouse liver carcinogenesis: mechanisms and relevance. Fundam. Appl. Toxicol. 1991; 17: 651–665
  • Richardson K. K., Rexroat M. A., Helvering L. M., Copple D. M., Richardson F. C. Temporal changes in the mutant frequency and mutation spectra of the 61st codon of the H-ras oncogene following exposure of B6C3F1 mice to N-nitrosodiethylamine (DEN). Carcinogenesis 1992; 13: 1277–1279
  • Sohn Y. W., Lee G. H., Liem A., Miller J. A. Activation of H-ras oncogenes in male B6C3F1 mouse liver tumors induced by vinthionine or 2-chloroethyl-methyl sulfide. Carcinogenesis 1996; 17: 1361–1364
  • Helvering L. M., Richardson F. C., Horn D. M., Rexroat M. A., Engelhardt J. A., Richardson K. K. H-ras 61st codon activation in archival proliferative hepatic lesions isolated from female B6C3F1 mice exposed to the leukotriene D4-antagonist, LY171883. Carcinogenesis 1994; 15: 331–333
  • Manjanatha M. G., Li E. E., Fu P. P., Heflich R. H. H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice. J. Toxicol. Environ. Health 1996; 47: 195–208
  • McMahon G., Davis E., Wogan G. N. Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen- induced tumors. Proc. Natl. Acad. Sci. USA 1987; 84: 4974–4978
  • Mirvish S., Cividalli G., Berenblum I. Slow elimination of urethan in relation to its high carcinogenicity in newborn mice. Proc. Soc. Exp. Biol. Med. 1964; 116: 265–268
  • Rao K. V., Vesselinovitch S. D. Age- and sex-associated diethylnitrosamine dealkylation activity of the mouse liver and hepatocarcinogenesis. Cancer Res. 1973; 33: 1625–1627
  • Jannetti R. A., Anderson L. M. Dimethylnitrosamine demethylase activity in fetal, suckling, and maternal mouse liver and its transplacental and transmammary induction by polychlorinated biphenyls. J. Natl. Cancer Inst. 1981; 67: 461–466
  • Coccia P., Salmona M., Diomede L., Citti L., Mariani L., Romano M. Liver DNA alkylation after a single carcinogenic dose of dimethylnitrosamine to newborn and adult CFW Swiss mice. Chem.–Biol. Interact. 1988; 68: 259–271
  • Frei J. V. Toxicity, tissue changes and tumor induction in inbred Swiss mice by methylnitrosamine and -amide compounds. Cancer Res. 1979; 30: 11–17
  • Melikian A. A., Bagheri K., Hecht S. S., Hoffmann D. Metabolism of benzo[a]pyrene and 7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydro-benzo[a]-pyrene in lung and liver of newborn mice. Chem.–Biol. Interact. 1989; 69: 245–257
  • El-Bayoumy K., Shiue G. -H., Hecht S. S. Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice. Carcinogenesis 1989; 10: 369–372
  • Delclos K. B., E1-Bayoumy K., Hecht S. S., Walker R. P., Kadlubar F. F. Metabolism of the carcinogen [3H]6-nitrochrysene in the preweanling mouse: Identification of 6-aminochrysene-1,2-dihydrodiol as the probable proximate carcinogenic metabolite. Carcinogenesis 1988; 9: 1875–1884
  • Tjalve H., Castonguay A., Hecht S. S. Fate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in pregnant and newborn C57BL mice. IARC 1984; 57: 787–796
  • Fu P. P., Yang S. K. reoselective metabolism of polycyclic aromatic hydrocarbons. Environmental Carcinogens—Polycyclic Aromatic Hydrocarbon Research, S. K. Yang, Y. K. Cheng. The Health Publisher, Beijing 1990; 49-71
  • Hong F., Von Tungeln L. S., Fu P. P., Watson F. Stereoselective metabolism of benzo[a]pyrene, 7-chlorobenz[a]anthracene, and 7-nitrobenz[a]anthracene by liver microsomes of 15-day-old male B6C3F1 mice. 16th International Symposium on Polycyclic Aromatic Compounds, Charlotte, NC, November, 1997. abstract B-2
  • Fu P. P., unpublished data
  • Raza H., King R. S., Squires R. B., Guengerich F. P., Miller D. W., Freeman J. P., Lang N. P., Kadlubar F. F. Metabolism of 2-amino-α-carboline, a food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2. Drug Metab. Dispos. 1996; 24: 395–400
  • Von Tungeln L. S., King R. S., Bucci T. J., Kadlubar F. F., Fu P. P. Tumorigenicity and metabolism of 2-amino-α-carboline in the B6C3F1, neonatal mouse. Proc. Am. Assoc. Cancer Res. 1999; 40: A1000
  • King R. S., Doerge D., Lang N. P., Kadlubar F. F. Metabolic activation of N-hydroxy-2-amino-α-carboline (N-OH-AαC) and identification of the AαC-nucleotide adducts formed in vitro and in vivo. Pro. Am. Assoc. Cancer Res 1997; 38: A2270
  • Felton J. S., Knize M. G. Occurrence, identification, and bacterial mutagenicity of heterocyclic amines in cooked food. Mutat. Res. 1991; 259: 205–217
  • Fujii K., Sakai A., Nomoto K., Nakamura K. Tumor induction in mice administered neonatally with 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole or 2-aminodipyrido[1,2-a:3′,2′-d]imidazole. Cancer Lett. 1988; 41: 75–80
  • Lin D. X., Lang N. P., Kadlubar F. F. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Dispos. 1995; 23: 518–524
  • El-Bayoumy K., Shiue G. -H., Hecht S. S. Metabolism and DNA binding of 1-nitropyrene and 1-nitrosopyrene in newborn mice. Chem. Res. Toxicol 1988; 1: 243–247
  • Roe F. J., Carter R. L., Adamthwaite S. Induction of liver and lung tumours in mice by 6-aminochrysene administered during the 1st 3 days of life. Nature 1969; 221: 1063–1064
  • Busby W. F., Jr., Garner R. C., Chow F. L., Martin C. N., Stevens E. K., Newberne P. M., Wogan G. N. 6-Nitrochrysene is a potent tumorigen in newborn mice. Carcinogenesis 1985; 6: 801–803
  • Delclos K. B., Walker R. P., Dooley K. L., Fu P. P., Kadlubar F. F. Carcinogen-DNA adduct formation in the lungs and livers of preweanling CD-1 male mice following administration of [3H]-6-nitrochrysene, [3H]-6-aminochrysene, and [3H]-1,6-dinitropyrene. Cancer Res. 1987; 47: 6272–6277
  • Debaun J. R., Rowley J. Y., Miller E. C., Miller J. A. Sulfotransferase activation of N-hydroxy-2-acetylaminofluorene in rodent livers susceptible and resistant to this carcinogen. Proc. Soc. Exp. Biol. Med. 1968; 129: 268–273
  • King C. M., Phillips B. Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nuclei acid. Science 1968; 159: 1351–1353
  • Miller J. A. Sulfonation in chemical carcinogenesis-history and present status. Chem.–Biol. Interact. 1994; 92: 329–341

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.